Literature DB >> 8473745

Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.

A Sher1, I P Oswald, S Hieny, R T Gazzinelli.   

Abstract

Spleen cells from scid mice produce high levels of IFN-gamma when exposed to either live tachyzoites of Toxoplasma gondii or a soluble parasite extract. Small numbers of parasites are sufficient to stimulate this response, which is also induced by cell-free supernatants of cultured tachyzoites. The parasite molecules responsible for triggering IFN-gamma production are heat-labile but resistant to freezing and thawing. Depletion of NK cells or adherent cells from the splenocyte population abolishes the response. Moreover, cultured bone marrow-derived NK cells are stimulated by Toxoplasma to produce IFN-gamma, but only when supplemented with adherent peritoneal washout or thioglycollate-induced exudate cells. Supernatants of macrophages preincubated with T. gondii extract also induce IFN-gamma synthesis by cultured NK cells. Addition of neutralizing mAb against TNF-alpha abolishes the IFN-gamma response of scid spleen cells exposed to the parasite or of NK cells incubated with supernatants of adherent cells stimulated with T. gondii extract. Moreover, splenic adherent cells produce low levels of TNF-alpha in response to the parasite. Nevertheless, TNF-alpha alone is not sufficient to trigger IFN-gamma production from purified NK cell populations. These findings provide the first example of the stimulation of T-independent IFN-gamma production by a protozoan. The ability of T. gondii to trigger this pathway may underlie its induction of strong IFN-gamma-dependent nonspecific and specific cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473745

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  90 in total

1.  Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.

Authors:  W Däubener; B Spors; C Hucke; R Adam; M Stins; K S Kim; H Schroten
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.

Authors:  Chung-Dar Yang; Gan-Nan Chang; David Chao
Journal:  Parasitol Res       Date:  2003-11-06       Impact factor: 2.289

Review 3.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

4.  Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.

Authors:  C A Hunter; T Slifer; F Araujo
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.

Authors:  Kelly J Pittman; Laura J Knoll
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

6.  Parasites: what are they good for?

Authors:  Jason S Stumhofer; P'ng Loke
Journal:  Curr Immunol Rev       Date:  2013-08-01

Review 7.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

8.  Toxoplasma gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages.

Authors:  Z Y Li; C L Manthey; P Y Perera; A Sher; S N Vogel
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Resistance to Toxoplasma gondii in mice infected as neonates or exposed in utero.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  IL-6 promotes NK cell production of IL-17 during toxoplasmosis.

Authors:  Sara T Passos; Jonathan S Silver; Aisling C O'Hara; David Sehy; Jason S Stumhofer; Christopher A Hunter
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.